CJC 1295 DAC SPECIFICATIONS
AKA: CJC 1295 with DAC
Molecular Formula: C152H252N44O42
Molecular Weight: 3647.954 g/mol
PubChem: CID 56841945
Molecular Formula: C46H56N12O6
Molecular Weight: 873.032 g/mol
PubChem: CID 9919153
CAS Number: 87616-84-0
Potential of CJC-1295 & GHRP-6 Blend
CJC-1295 & GRHP-6 are well-known synthetic analogs of the growth hormone-releasing hormone (GHRH) and “hunger hormone” ghrelin. CJC-1295 binds to and interacts with the cognate receptor of GHRH in the anterior pituitary gland. It maintains the pulsatile production of growth hormone (GH) in the body, improving the overall physiological levels. GHRP-6, on the other hand, is known to interact with the growth hormone secretagogue receptor.
CJC-1295 acts by the molecular mimicry of the hormone ghrelin, causing a stimulation of the growth hormone secretion. Since growth hormone receptors are present in many cells in the body, the benefits of CJC-1295 are also widespread. These include immune system strengthening, fat-burning properties, antiaging effects on the skin, improvement of the sleep cycle and cognitive function, and the overall betterment of sexual health and mood.
Studies have highlighted that in conjunction, the two synthetic peptides CJC-1295 & GHRP-6 exhibit a synergism towards augmenting the physiological levels of GH. GHRP-6 improves the basal levels of GH in the body. Thus, GHRP-6 ensures that even when the GH level declines in the body, it is maintained higher than under normal physiological conditions in the absence of the synthetic peptide. CJC-1295 now acts on the higher basal level of GH set by GHRP-6. It thus promotes even higher production of GH in a pulsatile fashion.
Even though it is an opioid analog of the peptide, Metenkephalin, it lacks the opioid activity generally associated with these enkephalins. GRHP-6 is also different from the growth hormone-releasing hormone in that it lacks sequence action. It acts on a completely different receptor that has now been proved to be ghrelin. Various research conducted on mice showed significant changes in the overall health of animals dosed with GRHP-6. These effects included improved muscle growth, significant changes in body composition, improved glucose metabolism, improved cognitive function, and cardiac function.
Clinical trials on GRHP-6 have yielded results that declare GRHP-6 as a highly beneficial substance that can be used in various conditions. This novel approach suggests using GRHP-6 in growth hormone deficiency disorders, Multiple Organ Failure (MOF), cachexia or wasting, obesity, and various eating disorders. Due to its cytoprotective properties, its use has been advocated in myocardial infarction to reduce scarring in tissues affected by reperfusion injuries. GRHP-6 can be used as an antiaging agent that has the added benefit of improving sleep and cognitive function.
When used in combination, both these peptides act synergistically to bring about changes in the body by considerably increasing the growth hormone levels in the body. GRP-6 maintains a baseline growth hormone level, whereas CJC-1295 mainly stimulates a pulsatile secretion of the growth hormone. The combinational use of these two peptides has proved to benefit in improving appetite and sleep cycle significantly. Since most of the growth and repair occurs during sleep, it aids in cellular regeneration and repair and improves wound healing and nerve tissue protection.
CJC-1295 & GHRP-6 peptides have also been associated with nervous tissue protection and better wound healing. GHRP-6 provides additional benefits like stimulating appetite and improving the quality of sleep. A higher food intake helps to utilize the elevated GH levels and leads to muscle building, improved bone density, and overall higher growth. Our bodies are most receptive to the influence of GH during sleep. Hence, improved sleep helps to bring about the maximum influence of GH on various biological functions such as wound healing and boosting and regenerating immunity.